10% Of AIA Petitions Have Been For Pharma, Biologic Patents

Since September 2012, only about 10% of America Invents Act petitions have been targeted at the pharmaceutical and biologic industries, according to new data from the U.S. Patent and Trademark Office....

Already a subscriber? Click here to view full article